Prevention of Bone Metastases

Bone metastases continue to be a major cause of morbidity in cancer patients, but improved understanding of the biology of bone metastases has led to the identification of drugs that are of potential value in not only their treatment but also their prevention. This book, written by recognized expert...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Joerger, Markus (Επιμελητής έκδοσης), Gnant, Michael (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg, 2012.
Σειρά:Recent Results in Cancer Research, 192
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02416nam a22004575i 4500
001 978-3-642-21892-7
003 DE-He213
005 20151204175728.0
007 cr nn 008mamaa
008 120203s2012 gw | s |||| 0|eng d
020 |a 9783642218927  |9 978-3-642-21892-7 
024 7 |a 10.1007/978-3-642-21892-7  |2 doi 
040 |d GrThAP 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Prevention of Bone Metastases  |h [electronic resource] /  |c edited by Markus Joerger, Michael Gnant. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2012. 
300 |a X, 234 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Recent Results in Cancer Research,  |x 0080-0015 ;  |v 192 
520 |a Bone metastases continue to be a major cause of morbidity in cancer patients, but improved understanding of the biology of bone metastases has led to the identification of drugs that are of potential value in not only their treatment but also their prevention. This book, written by recognized experts in the field, provides a detailed overview of current knowledge on this subject. One important focus of the book is the efficacy of bisphosphonates in preventing bone metastases in patients with breast, lung, and prostate cancer and disease progression in cases of multiple myeloma.  The combined use of bisphosphonates and cytostatics is also discussed, with a report on first clinical data.  Further topics addressed include the significance of the bone microenvironment, special issues in the elderly patient, the use of bone turnover markers, and initial findings obtained with denosumab. 
650 0 |a Medicine. 
650 0 |a Oncology. 
650 0 |a Surgical oncology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Oncology. 
650 2 4 |a Surgical Oncology. 
700 1 |a Joerger, Markus.  |e editor. 
700 1 |a Gnant, Michael.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642218910 
830 0 |a Recent Results in Cancer Research,  |x 0080-0015 ;  |v 192 
856 4 0 |u http://dx.doi.org/10.1007/978-3-642-21892-7  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)